Nevro Corp
Clinical trials sponsored by Nevro Corp, explained in plain language.
A medical device company focused on spinal cord stimulation for chronic pain.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New implant offers hope for stubborn back pain sufferers
Disease control CompletedThis study looked at a device called Nevro1, which is a titanium cage implanted in the sacroiliac joint to stabilize it and encourage bone fusion. Researchers wanted to see if it could safely reduce pain and improve function in 180 adults with chronic sacroiliac joint dysfunction…
Sponsor: Nevro Corp • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Electric pulses in the spine may ease diabetic nerve pain
Symptom relief CompletedThis trial compares a spinal cord stimulation device (HF10 therapy) plus standard medical care against standard care alone for people with long-term, hard-to-treat leg pain caused by diabetic neuropathy. About 430 adults with stable pain levels and no major neurological changes a…
Phase: NA • Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New device offers hope for back pain sufferers who Can't go under the knife
Symptom relief CompletedThis study tested a device called HF10 therapy (Senza spinal cord stimulator) against standard medical care for 211 people with long-term back pain who are not candidates for surgery. The goal was to see if the device could safely reduce pain by at least 50% and improve quality o…
Phase: NA • Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC